-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades RAPT Therapeutics to Hold

Benzinga·01/20/2026 18:25:48
Listen to the news
TD Cowen analyst Yaron Werber downgrades RAPT Therapeutics (NASDAQ:RAPT) from Buy to Hold.